Research Topics
Species | Dmitriy N FeldmanSummaryAffiliation: Cornell University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysisDmitriy N Feldman
Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
Catheter Cardiovasc Interv 77:1020-30. 2011..The aim of this meta-analysis was to assess the prevalence and prognostic value regarding mortality of cTnT or cTnI elevations after nonemergent percutaneous coronary intervention (PCI) in a large number of cohort/registry studies...
Reperfusion therapy in ST-elevation myocardial infarction: guidelines, strategies, pharmacology, and stent selectionB D Ghosh
Department of Medicine, New York Presbyterian Hospital, New York, NY, USA
Minerva Med 103:431-9. 2012..This review will discuss the current STEMI guidelines and strategies, recent advances in pharmacotherapy, and data on stent selection...- Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromesDmitriy N Feldman
Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA
Am J Cardiol 105:323-32. 2010..927). In conclusion, treatment with a 600-mg loading dose <2 hours before PCI is associated with similar short-term ischemic outcomes and long-term mortality compared to the currently recommended clopidogrel pretreatment regimen... - Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromesDmitriy N Feldman
Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
Catheter Cardiovasc Interv 76:513-24. 2010..This study sought to investigate if the efficacy of bivalirudin monotherapy is similar to heparin plus GP IIb/IIIa inhibition in patients with acute coronary syndromes (ACS) treated with clopidogrel following diagnostic angiography... - Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary interventionDmitriy N Feldman
New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
J Invasive Cardiol 21:258-63. 2009.... - Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomesDmitriy N Feldman
New York Presbyterian Hospital, Weill Cornell Medical College, New York, USA
Am J Cardiol 104:1210-5. 2009.... - Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stentsDmitriy N Feldman
Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, NY 10021, USA
Am Heart J 154:695-701. 2007..We investigated whether long-term outcomes after bivalirudin use remained comparable to heparin plus GP IIb/IIIa blockade in current clinical practice of drug-eluting stent use... - Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practiceLuke K Kim
New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, New York, NY 10021, USA
J Invasive Cardiol 22:94-100. 2010..This study sought to evaluate the short- and long-term efficacy and safety of bivalirudin in diabetic patients undergoing percutaneous coronary intervention (PCI) in contemporary clinical practice... 
Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplastyAshish Shah
Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY 10021, USA
Vasc Health Risk Manag 8:115-23. 2012..These results further support the use of bivalirudin in the setting of primary PCI for STEMI given that its benefits are maintained through long-term follow-up...- Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis as measured using cardiac biomarkersRobert M Minutello
Department of Medicine, Division of Cardiology, Weill Cornell Medical College, New York, New York 10065, USA
Tex Heart Inst J 37:161-5. 2010.... - Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry)Dmitriy N Feldman
Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
Am J Cardiol 99:446-9. 2007..In conclusion, as currently practiced in New York State, the strategy of ad hoc PCI in selected patient cohorts appears to be as safe as the strategy of staged procedures... - Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent eraScott Midwall
Greenberg Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York 10021, USA
J Invasive Cardiol 25:132-6. 2013..This study sought to compare short- and long-term (4-year) outcomes in patients with and without peripheral vascular disease (PVD) following non-emergent percutaneous coronary intervention (PCI) in current clinical practice... - Impact of Long-term Statin Therapy on Postprocedural Myocardial Infarction in Patients Undergoing Nonemergency Percutaneous Coronary InterventionJonathan Gordin
Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York
Am J Cardiol 110:1397-404. 2012..In patients with unstable coronary syndromes, long-term statin therapy may be beneficial, particularly at a high dose... - Nonsystem Reasons for Delay in Door-to-Balloon Time and Associated In-Hospital Mortality: A Report From the National Cardiovascular Data RegistryRajesh V Swaminathan
New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, New York, New York Electronic address
J Am Coll Cardiol 61:1688-95. 2013..The goal of this study was to characterize nonsystem reasons for delay in door-to-balloon time (D2BT) and the impact on in-hospital mortality... - Novel antiplatelet therapiesLuke Kim
Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
Curr Atheroscler Rep 14:78-84. 2012..The field of pharmacotherapy continues to rapidly evolve as newer agents, such as thrombin receptor antagonists, along with older agents, such as cilostazol and glycoprotein IIb/IIIa inhibitors, are being explored... - Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft diseaseRobert M Minutello
New York Presbyterian Hospital, Weill Cornell Campus, New York, New York, USA
J Interv Cardiol 20:458-65. 2007..The purpose of this study was to evaluate the efficacy of sirolimus-eluting stents (SES) in the treatment of saphenous vein graft (SVG) disease... - Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry)Dmitriy N Feldman
Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
Am J Cardiol 98:1334-9. 2006..Elderly patients, in particular octogenarians undergoing emergency PCI, have a substantially higher risk of in-hospital death... - Pharmacotherapy for the reduction of stent thrombosisDavid C Yang
Weill Cornell Medical College, New York Presbyterian Hospital, Department of Medicine, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
Expert Rev Cardiovasc Ther 11:567-76. 2013..In this review, evidence related to the various pharmacological agents for reduction of stent thrombosis available to clinicians during and after PCI will be explored... - Unplanned staged hybrid management of postmyocardial infarction ventricular septal defectDimitrios V Avgerinos
Department of Cardiothoracic Surgery, New York Presbyterian Hospital Weill Cornell Medical Center, New York, NY, USA
Cardiology 118:38-41. 2011..This case demonstrates the successful application of an unplanned, staged hybrid approach utilizing initial percutaneous and subsequent surgical repair after recovery of tissue integrity... - Images in cardiology: macroscopic T-wave alternansDmitriy N Feldman
Division of Cardiology, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, New York, USA
Clin Cardiol 29:422. 2006 - Ruptured aneurysm of the right sinus of valsalva associated with a ventricular septal defect and an anomalous coronary arteryDmitriy N Feldman
Division of Cardiology, Weill Medical College of Cornell University, 525 East 68th Street, New York, New York 1002, USA
Tex Heart Inst J 32:555-9. 2005..Previously published reports of the coexistence of a single coronary artery with a sinus of Valsalva aneurysm or with a ventricular septal defect, and their management, are discussed herein...